Wilsey Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-153,980
Closed -$9.96M 23
2019
Q4
$9.96M Buy
153,980
+4,575
+3% +$298K 3.61% 15
2019
Q3
$9.5M Buy
149,405
+12,078
+9% +$790K 3.73% 15
2019
Q2
$9.3M Buy
137,327
+3,431
+3% +$226K 3.82% 15
2019
Q1
$8.74M Buy
133,896
+6,753
+5% +$449K 3.65% 15
2018
Q4
$7.88M Buy
127,143
+6,050
+5% +$423K 3.83% 16
2018
Q3
$9.41M Sell
121,093
-2,261
-2% -$171K 4.07% 14
2018
Q2
$8.72M Sell
123,354
-27
-0% -$1.91K 4.5% 14
2018
Q1
$9.23M Buy
123,381
+1,289
+1% +$102K 5.06% 11
2017
Q4
$8.75M Buy
122,092
+5,889
+5% +$447K 4.91% 12
2017
Q3
$9.61M Sell
116,203
-4,051
-3% -$310K 6.2% 8
2017
Q2
$8.49M Buy
120,254
+2,651
+2% +$176K 6.17% 8
2017
Q1
$8.03M Buy
117,603
+3,042
+3% +$214K 5.62% 9
2016
Q4
$8.47M Buy
114,561
+16,810
+17% +$1.25M 5.99% 6
2016
Q3
$7.59M Buy
97,751
+1,355
+1% +$110K 5.84% 9
2016
Q2
$8.04M Buy
96,396
+504
+0.5% +$44.7K 5.75% 6
2016
Q1
$8.81M Sell
95,892
-265
-0.3% -$23.9K 6.18% 4
2015
Q4
$9.73M Buy
96,157
+286
+0.3% +$29.8K 7.01% 3
2015
Q3
$9.41M Buy
95,871
+5,755
+6% +$639K 7.28% 3
2015
Q2
$10.6M Buy
90,116
+615
+0.7% +$67.2K 8.52% 3
2015
Q1
$8.81M Buy
89,501
+24,730
+38% +$2.51M 6.58% 4
2014
Q4
$6.11M Buy
64,771
+21,630
+50% +$2.24M 4.28% 11
2014
Q3
$4.59M Sell
43,141
-36
-0.1% -$3.52K 3.67% 14
2014
Q2
$3.58M Buy
+43,177
New +$3.36M 2.79% 18

Other funds holding GILD

Wilsey Asset Management's GILD Position: Q1 2020 in Review

Wilsey Asset Management sold out of Gilead Sciences (GILD) in Q1 2020, closing a stake of 153,980 shares — an estimated $9.96M sold.

Wilsey Asset Management first reported a position in GILD in Q2 2014 and held it in 23 quarters. The position peaked at $10.6M in Q2 2015. 1,643 funds tracked by Wall St. Rank hold GILD as of Q1 2020.

  • Wilsey Asset Management reported no remaining Gilead Sciences position as of Q1 2020 after selling out during the quarter.
  • Wilsey Asset Management sold 153,980 Gilead Sciences shares in Q1 2020, an estimated $9.96M.
  • Wilsey Asset Management first reported a position in Gilead Sciences in Q2 2014 and held it in 23 quarters.
  • Wilsey Asset Management's Gilead Sciences position peaked at $10.6M in Q2 2015.
  • 1,643 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.

Based on Wilsey Asset Management's 13F filing for Q1 2020, filed 7 May 2020.